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Abstract
Background: Protein-protein interactions play a crucial role in enabling a pathogen to survive within a host. In many cases
the interactions involve a complex of proteins rather than just two given proteins. This is especially true for pathogens like
M. tuberculosis that are able to successfully survive the inhospitable environment of the macrophage. Studying such
interactions in detail may help in developing small molecules that either disrupt or augment the interactions. Here, we
describe the development of an E. coli based bacterial three-hybrid system that can be used effectively to study ternary
protein complexes.
Methodology/Principal Findings: The protein-protein interactions involved in M. tuberculosis pathogenesis have been used
as a model for the validation of the three-hybrid system. Using the M. tuberculosis RD1 encoded proteins CFP10, ESAT6 and
Rv3871 for our proof-of-concept studies, we show that the interaction between the proteins CFP10 and Rv3871 is
strengthened and stabilized in the presence of ESAT6, the known heterodimeric partner of CFP10. Isolating peptide
candidates that can disrupt crucial protein-protein interactions is another application that the system offers. We
demonstrate this by using CFP10 protein as a disruptor of a previously established interaction between ESAT6 and a small
peptide HCL1; at the same time we also show that CFP10 is not able to disrupt the strong interaction between ESAT6 and
another peptide SL3.
Conclusions/Significance: The validation of the three-hybrid system paves the way for finding new peptides that are
stronger binders of ESAT6 compared even to its natural partner CFP10. Additionally, we believe that the system offers an
opportunity to study tri-protein complexes and also perform a screening of protein/peptide binders to known interacting
proteins so as to elucidate novel tri-protein complexes.
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Introduction
M. tuberculosis continues to spread and kill millions despite the
availability of vaccines and drugs that can combat the pathogen
[1]. Recent emergence of strains that are resistant to all of the
current front-line Tuberculosis (TB) drugs has caused world-wide
alarm, and there is an urgent need for the development of new and
more efficient drugs and simple diagnostic tools to help fight the
scourge [2,3].
A characteristic feature of M. tuberculosis is its ability to remain
dormant in the host for years [4]. It enters the human body
through the respiratory tract, gets engulfed by the phagocytic cells
and is carried across the alveolar epithelium to the lungs, where a
dynamic process of sequestration and infection of fresh phagocytic
cells by the pathogen and formation of granuloma takes place
[5,6]. During this entire process, and also during the stage of
progressive infection, a series of protein-protein interactions within
the pathogen as well as at the host-pathogen interface takes place
[7–9]. This enables the pathogen to adapt to the inhospitable
changes in the immediate environment and eventually get
established as a persistent infection.
Several studies have been carried out to understand the
complex nature of these protein-protein interactions. Two
mycobacterial secretory proteins, SapM [10] and PtpA [11] have
been shown to directly interfere with the host physiological
processes, resulting in maturation arrest of the mycobacterial
phagosome. The RD1 region encoded virulence determining
factors, CFP10 and ESAT6 are another set of secretory proteins
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strong 1:1 heterodimeric complex which is recognized and
subsequently secreted with the aid of a specialized secretory
system called the EsxI system [12–15]. Recent studies have shown
that the EsxI secretory system is complex in nature and involves
several proteins that assist in the secretion of its substrates CFP10
and ESAT6. An EsxI secretory system protein Rv3871 is a
cytosolic ATPase that has been shown to bind to the C-terminal of
CFP10 in the ESAT6 : CFP10 complex and escort it to Rv3870,
the membrane-bound component of the EsxI system protein, and
thereby allow its secretion [14]. The system has several other
substrates that are co-secreted and are mutually dependent upon
each other for secretion, such that the inhibition of secretion of any
of these substrates can affect the secretion of the rest of the
substrates [16]. Through functional and comparative genomic
studies, it is now known that the secretion of ESAT6 and CFP10 is
crucial for stimulating host immunogenicity [17] while imparting a
fully virulent phenotype to M. tuberculosis [13,18,19]. ESAT6 has
been known to be involved in the dissemination of the pathogenic
mycobacterium within the host body and shown to directly
interact with the host epithelial cell protein MMP9 to induce
granuloma formation [20,21].
Given the fact that protein-protein interactions are fundamental
for pathogenesis, disruption of any of these interactions can have a
debilitating effect on the normal sustenance of the pathogen within
the host system [22,23]. Disrupting protein-protein interactions
using a bacterial three-hybrid system, therefore, provides a viable
approach towards deciphering the interaction mechanisms
involved, besides presenting new avenues for pharmacological
applications. Conventional strategies for disruption of known and
crucial protein-protein interactions involve the use of small
molecules that can enter the infected cell in question and perform
the disruption [22,24]. These molecules are, more often than not,
representatives from a chemically synthesized combinatorial
library or from defined/undefined compound libraries collected
over decades. In contrast, using de novo proteins and peptides as
‘interactors’ offers a feasible alternative to this approach as it
allows us to sift through the protein space and explore a myriad of
proteins from a given de novo protein library, so as to isolate
peptides/proteins that may interact and then possibly disrupt a
given protein-protein interaction [25,26]. To make use of such an
approach, what is required is a viable system that can express the
genes corresponding to the de novo peptides or proteins, and then
present such peptides and proteins to an interacting protein
complex at the first place.
Ideally, such a system should (a) enable the expression of three
different genes in a single bacterial system in a regulated manner,
(b) facilitate simple detection of the effect of association of a third
protein on two interacting proteins, and (c) efficiently allow the use
of de novo peptide libraries in the three-hybrid set-up. In this report,
we describe the development and functional analysis of an E. coli
based bacterial three-hybrid system that addresses all of the above-
mentioned concerns.
Results
Construction of a bacterial three-hybrid system
The three-hybrid system was decided to be based on an original
transcriptional activation dependent bacterial two-hybrid system
that was introduced by Dove and coworkers [27,28]. This two-
hybrid system has been used extensively over the past decade to
study and validate interactions between any two given proteins.
The ‘read-out’ of a successful interaction is visual (appearance of
blue-colored colonies) as it is based on the lacZ-Xgal ‘blue-white’
selection, and the strength of the interaction can be easily
monitored using the ‘lacZ activity’ assay [28]. We decided to build
on this system and develop a simple method wherein a ‘blue
reporter’ strain (indicative of a successful protein-protein interac-
tion), carrying the interacting bait and target proteins could be
transformed with a vector carrying a gene that would express a
third protein. Upon induction, the expression of this third protein
could affect the bait and target protein interaction and bring about
its manifestation in the form of an altered level of reporter gene
transcription. In other words, if the third protein were to augment
the target and bait interaction, the blue color would become more
intense; on the other hand, if the said interaction was disrupted by
the third protein, the effect would be a decrease in lacZ enzyme
activity, leading to a change in color from blue to white. The
three-hybrid system and its potential uses are shown schematically
in Figure 1A, 1B and 1C.
For the construction of the bacterial three-hybrid system, a new
vector plasmid was required, that could coexist in the reporter
strain along with the bait and the target plasmids, and carry a
promoter that would allow differential regulation of expression of
the third gene. A novel streptomycin-resistant pMTSA vector was
thereby constructed that had all the elements required for its
viability in the newly developed system (see Materials and
Methods). The integrity of the vector was confirmed by restriction
enzyme digestion and sequencing. To check for its functionality,
Rv3871 gene was cloned in the pMTSA vector and the resulting
plasmid used to transform the bacterial two-hybrid ‘R1’ strain. A
robust expression of the Rv3871 protein under arabinose
induction was observed (Figure S1). The system was now ready
to be used for the study of ternary protein complexes.
The CFP10, Rv3871, ESAT6 tri-protein complex
Interactions between the M. tuberculosis EsxI proteins CFP10 and
ESAT6, as well as between CFP10 and Rv3871 have recently
been elucidated in seminal studies by Cox and co-workers and a
model for the export of ESAT6 protein has been proposed [14].
According to this model, the C-terminal end of CFP10 protein
interacts with Rv3871, triggering the eventual export of the
CFP10 : ESAT6 heterodimeric complex itself (the punctuation
mark ‘‘:’’ denotes an interacting protein complex.) We were
interested in studying this tri-protein complex in order to ascertain
whether ESAT6 has a role in CFP10 : Rv3871 protein-protein
interaction. In vivo validation of the interaction between CFP10
and ESAT6, as well as CFP10 and Rv3871 was first achieved
using the bacterial two-hybrid system. Appearance of dark blue
color in the ‘CFP10 : ESAT6 strain’ and lighter blue color in the
‘CFP10 : Rv3871 strain’ indicated the relative strength of
interaction (Fig 2A). The results were in accordance with
previously published reports [14] and also ensured that the folding
and the subsequent interaction of the concerned proteins were
appropriate in the bacterial strain. In vitro analysis of the CFP10 :
ESAT6 and CFP10 : Rv3871 protein-protein interactions was
carried out by Far-Western Dot Blot assay (Figure S2B) using
purified CFP10-GST (Glutathione S-transferase), Rv3871-His and
ESAT6-His proteins (Figure S2A; the punctuation ‘‘-’’ denotes a
fusion protein or a protein fused to a peptide-tag). Quantification
of the density of blot color was done by Spot Densitometric
analysis (Figure S2C). Observation of a strong interaction between
CFP10 : ESAT6 and a weak but significant interaction between
CFP10 : Rv3871 helped us further confirm the concerned protein-
protein interactions.
Before commencing our three-hybrid studies, we decided to first
profile the interaction of Rv3871 with CFP10-ESAT6 and
ESAT6-CFP10 fusion proteins using the two-hybrid system. We
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protein’ system, we could establish if Rv3871 interacted more
strongly with CFP10 when the latter was in fusion with its natural
partner ESAT6 than when CFP10 was on its own. It is known that
CFP10, by forming a 1:1 heterodimeric complex with ESAT6,
undergoes a conformational change and attains higher thermo-
Figure 2. CFP10 : Rv3871 protein-protein interaction. (A) Bacterial two-hybrid X-Gal plate showing co-transformants: CFP10pBTnn +
ESAT6pTRGnn (positive control); CFP10pBTnn + Rv3871pTRGnn; CFP10-ESAT6pBTnn + Rv3871pTRGnn; and pBTnn + Rv3871pTRGnn (negative
control). ‘‘+" denotes the fact that two or more proteins (or plasmids) are present together, either within a strain or in vitro. Two different colonies of
each co-transformant were patched. (B) Quantitative analysis by liquid b-galactosidase assay. All interactions were found to be statistically significant
(*, P,0.001; **, P,0.05).
doi:10.1371/journal.pone.0027503.g002
Figure 1. Schematic representation of the bacterial three-hybrid system. The diagram represents the effect of expression of a third protein
under arabinose induction on the interaction of IPTG-inducible bait and target proteins. Here A and B represent the bait and target proteins
respectively, whereas C represents the protein expressed by the gene cloned in pMTSA vector. (A) Protein C acting as an inducer of interaction
between proteins A and B. (B) Protein C acting as a disruptor of interaction between proteins A and B. (C) Protein C acting as a mediator of interaction
between proteins A and B.
doi:10.1371/journal.pone.0027503.g001
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therefore, that the interaction of Rv3871 with CFP10 is affected by
the presence or absence of ESAT6.
To avoid any discrepancy in terms of conformation, both fusion
orientations i.e. CFP10-ESAT6 and ESAT6-CFP10 were con-
structed and analyzed. Interaction strength of Rv3871 with the
fusion constructs was found to be comparable to that with CFP10
alone (Fig 2A; Figure S3A). Corroboration of all visual
observations was carried out by the quantitative liquid b-
galactosidase assay (Fig 2B; Figure S3B). Rv3871 was found to
bind both fusion constructs with equal strength, notwithstanding
the fact that in one of the fusion constructs – CFP10-ESAT6 – the
C-terminal end of CFP10 is covalently tethered and not free to
interact with Rv3871. This may point to the fact that factors other
than the C-terminal chain of CFP10 are involved in the
interaction, although this could also be due to the fact that the
flexible N-terminal of ESAT6 acts as a linker allowing the C-
terminal of CFP10 to be available for other binding partners.
Clearly, using a two-hybrid approach was not going to be sufficient
for studying tri-protein complexes even though two of the
constituent proteins formed a natural association with each other.
Utilizing the bacterial three-hybrid system, that enables three
proteins to be expressed simultaneously yet exclusive to each
other, we believed, was therefore ideally suited for such tri-protein
complex studies. Firstly, it would allow their interactions to mimic
the natural complex more closely. Additionally, in the context of
CFP10, ESAT6 and Rv3871, the three proteins would be allowed
to express independently in a system, rather than as fusion
constructs. With this in mind, a three-hybrid approach was
adapted. The ‘blue reporter strain’ carrying CFP10pBTnn and
Rv3871pTRGnn plasmids was transformed with ESAT6pMTSA
(test) or pMTSA (control) plasmids separately and plated on X-Gal
arabinose indicator plates. Deep blue-colored colonies in the strain
carrying ESAT6pMTSA, whereas lighter blue color in the strain
carrying empty pMTSA plasmid, were observed (Fig 3A).
Random colonies from each plate were picked and checked for
the presence of all the three plasmids.
For a quantitative study of the above observation, time-
dependent liquid b-galactosidase assay was carried out. A graph
of b-galactosidase activity of each sample plotted against time
showed a significant difference in the activity of test and control
samples (P,0.05). The enzyme activity in the strain carrying
ESAT6pMTSA was found considerably higher than that in the
control strain (Fig 3B).
An RT-PCR based analysis was used to determine the level of
transcription of the lacZ reporter gene in the test and control
Figure 3. Representation of the CFP10 : Rv3871 : ESAT6 interaction in bacterial three-hybrid system. (A) X-Gal Arabinose indicator plate
showing triple co-transformants: CFP10pBTnn + Rv3871pTRGnn + ESAT6pMTSA; and CFP10pBTnn + Rv3871pTRGnn + pMTSA. Two separate colonies
from each co-transformant plate were picked and patched. (B) Time course liquid b-galactosidase assay: Relative b-galactosidase activity of the triple
co-transformants (m) CFP10pBTnn + Rv3871pTRGnn + pMTSA; and (&) CFP10pBTnn + Rv3871pTRGnn + ESAT6pMTSA is plotted against time-points
of bacterial culture growth, with 0 time-point being the point of arabinose induction. The graph is the average of three independent assays and
standard deviation is represented as error bars. (P,0.05 at all time points beyond 60 minutes). (C) Relative fold change of lacZ gene transcripts in
Bacterial three-hybrid system: Approximately two-fold increase in lacZ gene transcription is observed in comparison to negative control when CFP10
and Rv3871 interact in the presence of ESAT6 in the three-hybrid system. (*, P,0.01).
doi:10.1371/journal.pone.0027503.g003
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galactosidase assays. Approximately two-fold increase in lacZ gene
transcription was obtained in the CFP10 : Rv3871 : ESAT6 strain
compared with the negative control (Fig 3C). An RT-PCR analysis
to check the level of expression of CFP10 and Rv3871 was also
conducted. We found no difference in transcription levels in the
test and control strains (Figure S4) demonstrating that the
difference in the extent of interaction indicated by the strength
of blue color and the lacZ gene expression was solely because of the
presence or absence of ESAT6 in the three-hybrid strain and not
because of the differential expression of CFP10 and Rv3871.
The ESAT6, HCL1, CFP10 tri-protein complex
As previously mentioned, the interaction between ESAT6 and
CFP10 has been well established and efforts to discover binders to
these ‘virulence determinants’ of M. tuberculosis are underway
[12,29,30]. Recently, Kumar et al have reported another peptide
HCL1, isolated from human lung cDNA library, that shows strong
interaction with ESAT6 of both M. tuberculosis as well as M.
smegmatis, with its in vivo expression severely impairing M. tuberculosis
growth [31]. We decided to test the efficacy of the three-hybrid
system using proteins CFP10, ESAT6 and HCL1. Verification of
these interactions was first achieved by the standard bacterial two-
hybrid assay which showed strong interaction between ESAT6
and CFP10, as well as between ESAT6 and HCL1 (Figure S5A). A
liquid b-galactosidase assay estimation showed that the interaction
between ESAT6 and CFP10 was a little stronger compared to that
between ESAT6 and HCL1 (Figure S5B). Further analysis using in
vitro Far-Western Dot Blot assay showed that HCL1 interacted
strongly with ESAT6 while not at all with CFP10 (Figure S5C).
To explore how these three proteins would behave when all
three of them are present in the same system, ESAT6 and CFP10
were taken as bait and target proteins respectively and the
resulting ‘blue strain’ was transformed with HCL1pMTSA (test) or
pMTSA (control) plasmids. No considerable variation in blue
color of the colonies in test and control plates was observed. The
observation was confirmed by liquid b-galactosidase assay (data
not shown). This meant that, upon arabinose induction and
expression, HCL1 was not able to disrupt ESAT6 : CFP10
interaction.
To investigate the possibility whether CFP10, instead, could
disrupt the interaction between ESAT6 and HCL1, the ‘blue
strain’ carrying ESAT6pBTnn and HCL1pTRGnn plasmids was
transformed with CFP10pMTSA (test) or pMTSA (control)
plasmids. Herein, an interesting observation on the X-Gal
arabinose indicator plate was made. The colonies on control
plate remained blue, while those on test plate had turned white
(Fig 4A). Liquid b-galactosidase assay showed a five-fold decrease
Figure 4. Representation of ESAT6 : HCL1 protein-protein disruption by CFP10 in bacterial three-hybrid system. (A) X-Gal indicator
plate with and without arabinose patched with ESAT6pBTnn + HCL1pTRGnn + pMTSA; and ESAT6pBTnn + HCL1pTRGnn + CFP10pMTSA. Blue colony
turns white when CFP10 is allowed to express in the presence of 1% arabinose. (B) Time course liquid b-galactosidase assay: b-galactosidase activity
of above triple co-transformants: (&) ESAT6pBTnn + HCL1pTRGnn + pMTSA; and (N) ESAT6pBTnn + HCL1pTRGnn + CFP10pMTSA is plotted against
time-points of bacterial culture growth with 0 time-point being the point of arabinose induction. Standard deviation of the activities obtained in
three separate assays is shown by error bars. (P,0.05 at all time-points beyond 60 minutes) (C) Arabinose gradient liquid b-galactosidase assay:
Relative b-galactosidase activity of triple co-transformants (N) ESAT6pBTnn + HCL1pTRGnn + CFP10pMTSA; and (&) ESAT6pBTnn + HCL1pTRGnn +
pMTSA is plotted against arabinose concentration. The graph is the average of three separate assays and standard deviation is represented as error
bars. (P,0.05 at all arabinose concentrations beyond 0.01%).
doi:10.1371/journal.pone.0027503.g004
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control sample (Fig 4B). No indication of the CFP10 expression
having a toxic effect on cells was observed. Transforming the
ESAT6 : HCL1 blue strain with a dummy (unrelated protein) non-
interactor HLL7pMTSA plasmid gave same results as the negative
control (Figure S6A, B).
Our next objective was to check the effect varying concentra-
tions of the inducer arabinose may have over the ESAT6 : HCL1
protein-protein disruption by CFP10. An arabinose gradient liquid
b-galactosidase assay was performed. It was hypothesized that with
increasing concentration of arabinose, expression of CFP10 in the
strain would increase, which, in turn, should enhance the extent of
disruption of ESAT6 : HCL1 interaction. A graph of enzyme
activity versus arabinose concentration clearly showed more than
three-fold decrease in activity of the test sample with increasing
arabinose concentration, while no considerable change in activity
in case of negative control was observed (Fig 4C).
To further test the stringency of our system, we wanted to
investigate the behavior of CFP10 in the presence of a binder that
bound ESAT6 more strongly than CFP10 itself. A bacterial two-
hybrid screen was carried out using ESAT6 and the human lung
cDNA library, cloned in pBTnn and pTRG vectors respectively.
The experiment yielded a range of ESAT6 binders, named SL1-6.
The binders were found to be small peptides having no homology
with any known human protein (Fig 5A). On quantification of the
strength of interaction, two peptides: SL3 and SL4, were observed
to have a binding strength higher than ESAT6 : CFP10 (Fig 5B).
The stronger of the two binders, SL3, was investigated further
using the bacterial three-hybrid assay system. The ‘blue reporter
strain’ carrying ESAT6pBTnn and SL3pTRGnn was transformed
with CFP10pMTSA (test) or pMTSA (control) plasmids and
plated on arabinose positive and arabinose negative X-Gal
indicator plates. Interestingly, presence or absence of CFP10 bore
no effect, either on the visual intensity of blue color of the ESAT6 :
SL3 strain (Fig 6A), or on its quantification by b-galactosidase
assay (data not shown).
RT PCR analysis to quantify the lacZ gene transcription levels
for both ESAT6 binders, HCL1 and SL3, was carried out. Indeed,
the fold difference in the transcription levels for ESAT6 : HCL1,
and ESAT6 : SL3, in presence and absence of CFP10,
corroborated all our previous observations. A four-fold decrease
was observed in the ESAT6 : HCL1 strain in the presence of
CFP10 (in comparison with the negative control), while no
significant difference for ESAT6 : SL3 reporter strain either in
presence or in absence of CFP10 was observed (Fig 6B).
Unearthing peptides that form tri-protein complexes
To investigate whether the three-hybrid system could be utilized
to effectively unearth proteins or peptides that take part in a tri-
protein complex, we decided to perform the following experiment:
The ‘non-interacting’ reporter strain R1 was co-transformed with
the plasmids CFP10pMTSA and ESAT6pBTnn and competent
cells (mCER1) made. The mCER1 competent cells were
transformed with an M. tuberculosis genomic DNA library (for the
construction of the library please see Materials and Methods).
Appearance of a blue-colored colony on plates that contained 1%
Arabinose was an indication that the expression of a library
member had facilitated the interaction between ESAT6 and
CFP10. The pTRGnn-based library member was isolated both
from a blue as well as a white colony, and used to retransform the
Figure 5. De novo ESAT6 binders. (A) Table showing peptide sequences of de novo ESAT6 binders. (B) Quantitative analysis of interacting strength
of the binders (SL1-SL6) by liquid b-galactosidase assay. ESAT6 : CFP10 binding strength is shown as control; SL3 and SL4 show higher binding
strength with ESAT6 compared to CFP10. Statistical significance was determined in comparison to the ESAT6 : CFP10 interaction (*, P,0.05;
**, P,0.1).
doi:10.1371/journal.pone.0027503.g005
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appeared strong blue were picked from the initial library screening
plate. Patching of these colonies along with the negative control
was done on the Arabinose positive and Arabinose negative X-Gal
Streptomycin plates. When observed for the development of blue
color, only two (B1, B4) out of the initial four stayed blue on the
Arabinose negative plate, while only B4 turned blue on the
Arabinose positive plate. It can be inferred that in strain B1, the
appearance of blue colored colony on Arabinose negative plate
indicates that the pTRGnn library member interacted with
ESAT6. Nonetheless, on Arabinose positive plate, the colony
color stayed white, which signifies that the interaction was negated
in the presence of CFP10 (the expression of CFP10 is regulated by
presence or absence of Arabinose). However, in strain B4, the
colony color was blue on both Arabinose positive and negative
plates, indicating that the pTRGnn library member interacted
with ESAT6 and the interaction was maintained even in the
presence of CFP10.
The pTRGnn plasmids of each strain (B1 and B4) were
segregated and used to re-transform the mCER1 compentent cells.
The re-transformed strains were plated on Arabinose positive as
well as Arabinose negative X-Gal Streptomycin plates. When
allowed to develop at 30uC, both the strains (Reco B1 and Reco
B4, Figure S7B) turned blue on the Arabinose negative plates,
while only Reco B4 turned blue on the Arabinose positive plate.
Sequencing of the pTRGnn plasmids B1 and B4 showed that both
were small peptides (Figure S7C). B4 might therefore be a peptide
candidate that forms a successful tri-protein complex with ESAT6
and CFP10. However, much more work needs to be done in this
direction in order to fortify these initial results and carry out
detailed analysis of the peptide and many other such proteins/
peptides that form tri-protein complexes in vivo.
Discussion
While a range of yeast two-hybrid and mycobacterial two-
hybrid systems have been used for studying protein-protein
interactions in M. tuberculosis [32–37], we believe that the use of
an E. coli based bacterial system offers a few advantages, such as 1)
ability to screen larger libraries 2) faster screening process 3) ability
to screen eukaryotic as well as mycobacterial proteins which could
be toxic or homologous to other proteins in the yeast and
mycobacterial systems, and 4) a much more efficient induction of
the proteins themselves.
Several modifications of yeast/bacterial two-hybrid systems in
the form of yeast/bacterial three-hybrid systems have been
Figure 6. Representation of ESAT6 : CFP10 : SL3 interaction in bacterial three-hybrid system. (A) X-Gal indicator plates (with and without
arabinose) showing triple co-transformants: ESAT6pBTnn + SL3pTRGnn + pMTSA; ESAT6pBTnn + HCL1pTRGnn + pMTSA; ESAT6pBTnn + SL3pTRGnn +
CFP10pMTSA; and ESAT6pBTnn + HCL1pTRGnn + CFP10pMTSA. Two different colonies of each co-transformant were patched. (B) Fold-difference of
lacZ gene transcript in the triple co-transformants relative to the ESAT6pBTnn + HCL1pTRGnn + pMTSA negative control strain. The lacZ gene
transcription is reduced approx. four-fold as compared to negative control when ESAT6 and HCL1 interact in presence of CFP10 in the bacterial three-
hybrid system (*, P,0.05), whereas no significant difference is observed in the ESAT6 : SL3 strain expressing CFP10 (**, P.0.05). The RT-PCR
experiment was performed in triplicate using 3 separate colonies.
doi:10.1371/journal.pone.0027503.g006
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small molecules only [38–41]. A few groups have modified the
yeast two-hybrid system to incorporate three different genes under
regulation of different promoters to allow their independent
expression and interaction [42–44]. Nevertheless, no such
significant modification has been reported in a bacterial two-
hybrid system except the one by Karimova and coworkers, which,
although efficient, does not allow independent regulation of
expression of the third gene [45].
In this report we have described a bacterial three-hybrid system
that is a modification on the commercially available two-hybrid
BacterioMatchI system [27,28]. The M. tuberculosis EsxI system
proteins have been used as a model for our studies.
To ascertain the utility of the system in studying tri-protein
complexes, we applied the system to investigate the role of ESAT6
in the binding of CFP10 with Rv3871. Because ESAT6 and
CFP10 form a tight 1:1 heterodimeric complex, we initially used
the standard two-hybrid system for studying the interaction of this
complex with Rv3871, employing CFP10 and ESAT6 fusion
constructs for this purpose. The results failed to throw more light
on the vital role ESAT6 might play in the CFP10 : Rv3871
complex formation. On the other hand, using the three-hybrid
system we were able to demonstrate conclusively the role of
ESAT6. The results obtained on X-Gal Arabinose indicator plate
(Fig 3A), liquid b-galactosidase assay (Fig 3B) and RT PCR
(Fig 3C) showed that presence of ESAT6 strengthens the binding
of CFP10 with Rv3871. It can be speculated from these
observations that the binding of ESAT6 to CFP10 brings about
certain conformational changes in the two proteins that then
induces the exposure of the C-terminal tail of CFP10, ultimately
making it available for stronger binding with Rv3871. Possibility of
a direct intervention by ESAT6 in the binding of the complex with
Rv3871 is also not ruled out, as indicated in a recent report by
Callahan et al [46].
We also tested the suitability of the three-hybrid system for
studying disruption of known protein-protein interactions by
subjecting ESAT6 and its two known binder peptides: CFP10
and HCL1, to three-hybrid analysis. The observation on the
X-Gal indicator plate and the quantitative analysis by liquid b-
galactosidase assay clearly showed that the stronger of the two
ESAT6 binders, CFP10, could dislodge the weaker binder HCL1.
Here, the disruptor gene cloned in pMTSA vector is tightly
regulated by the pBAD promoter allowing for its differential
expression. Therefore, patching the test strain on arabinose
positive and arabinose negative indicator plates enables a single
step confirmation of the disruption of two interacting proteins by
the third protein. Using the arabinose gradient liquid b-
galactosidase assay we have shown the extent to which the level
of expression of the pMTSA expressed gene (here CFP10) can be
regulated and its effect exhibited on the protein-protein interac-
tion. However, since HCL1 was a weaker binder of ESAT6
compared to CFP10, we next used a stronger binder, SL3, and
investigated whether CFP10 could still dislodge SL3 from ESAT6.
Absence of change in colony color on the arabinose positive and
arabinose negative indicator plates confirmed the fact that CFP10
was unable to disrupt ESAT6 : SL3 interaction (Fig 6A).
Clearly, the strength of interaction between ESAT6 and both its
non-natural binders, HCL1 and SL3, was different and affected its
ability to bind its natural ligand CFP10. RT-PCR analysis showed
that the strength of ESAT6 : SL3 interaction was approximately
two-fold higher than the ESAT6 : HCL1 interaction (Fig 6B).
Undoubtedly, while more work needs to be done to examine the
effect of SL3 on the overall viability of M. tuberculosis, the three-
hybrid system has indeed brought forth a binder, SL3, that binds
to the well-established M. tuberculosis drug target ESAT6 with a
binding strength higher than its natural ligand CFP10. Crucially, it
is a binding that CFP10 itself cannot disrupt. This finding, we
believe, has important implications for addressing inhibition of M.
tuberculosis virulence and further studies would shed more light on
the observed results.
That the three-hybrid approach could also be used to identify
peptides that facilitate the formation of a tri-protein complex was
also tested. A small peptide, B4, was seen to assist the formation of
a tri-protein complex between itself, ESAT6, and CFP10. While
these are initial studies and further work needs to be carried out to
strengthen the basic approach, it is encouraging to note that the
system offers discovery of small peptides that can bind to a known
protein complex, like ESAT6 and CFP10, and go on to form a
tri-protein complex. In M. tuberculosis, this application can be
exploited in studying complex systems like the EsxI secretory
system, where the interaction of proteins may occur only with
dimeric complexes like CFP10:ESAT6 rather than with individual
proteins. As dimerisation usually induces conformational changes
in the proteins that have dimerised, a two hybrid system is not
sufficient to study the interaction of a third protein with a member
of the heterodimeric complex.
From our proof-of-concept studies, we understand that the
bacterial three-hybrid system can be used not only for studying tri-
protein complexes, but also for protein-protein disruption studies.
For example, one could study the effect of a disruptor peptide (of say
a particular protein-protein interaction) on the downstream
biochemical pathway induced by the interaction itself. In the context
ofM.tuberculosis, thisparticular aspect could be vitalfor studying how
this pathogen is able to evade the host machinery and propagate.
There is however a caveat in using a bacterial system for
studying protein-protein interactions, especially when the interac-
tions concern eukaryotic proteins: a prokaryotic codon-bias may
result in low expression of the eukaryotic proteins; in some cases
constituent library members of a eukaryotic cDNA library may
even fail to express. One potential solution could be to allow for a
more broad-based codon-usage in the two-hybrid bacterial strain
that is used for the experiments. Additionally, for the eukaryotic
proteins that are ultimately unearthed as potent binders and
potential peptidomimetic templates for drugs against the target
bacterial proteins, a re-synthesis of their corresponding genes
keeping in mind a prokaryotic expression would permit further
E. coli-based in vitro and in vivo studies. Nonetheless, the speed and
ease with which eukaryotic protein/peptide entities can be
revealed through the use of a bacterial system make it, we believe,




All plasmids described in this work were sequenced for the
presence and integrity of their inserts using the Sanger method. No
new information regarding DNA sequence (new gene, organism,
etc.) was generated in the course of this work that merited
submission to GenBank.
Bacterial Two-Hybrid Studies
The bacterial two-hybrid studies were carried out using
Bacteriomatch
TM two-hybrid system vector kit (Stratagene,
USA). The kit was supplied with bacterial two-hybrid system
plasmids pBT, pTRG and control plasmids pBT-LGF2 and
pTRG-Gal11p. The pBT and pTRG vectors were modified to
have a unique SnaBI site in MCS for blunt end clonings and
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cDNA library (cloned in pTRG vector) was purchased from
Stratagene, USA. Full length genes for esat6 (Rv3875), cfp10
(Rv3874) and Rv3871 were amplified from M. tuberculosis (H37Rv)
genomic DNA using their respective forward and reverse primers
(Table 1). The PCR products were digested with SnaBI and cloned
in SnaBI-cut pTRGnn and pBTnn vectors. A fusion of CFP10 and
ESAT6 proteins (cfp10-esat6) was constructed where esat6 was fused
to the C-terminal of cfp10 gene. The CFP10pBTnn clone was
digested with ScaI at a site located immediately upstream of C-
terminal end of cfp10 gene to provide free blunt ends. SnaBI-
digested insert of esat6 gene was cloned at this site to yield the
CFP10-ESAT6pBTnn clone. Another fusion construct where esat6
was fused at the N-terminal of cfp10 gene (esat6-cfp10), was made
by cloning a SnaBI/ScaI digested cfp10 insert in SnaBI-cut pBTnn
vector backbone. Esat6 insert was then cloned in the SnaBI-
digested construct to give ESAT6-CFP10pBTnn. The genes
coding for HCL1 and SL3 peptides were obtained from human
lung cDNA library and recloned in pTRGnn vector using gene-
specific forward and reverse primers as described earlier [31].
Reporter strain competent cells were co-transformed with equal
amount (250 ng each) of the respective pBTnn and pTRGnn
clones and plated on X-Gal plates containing: kanamycin (50 mg/
mL), chloramphenicol (30 mg/mL), tetracycline (12.5 mg/mL), X-
Gal (80 mg/mL), IPTG (25 mM), and X-Gal inhibitor (phenyl-
methyl-b-D-thiogalactoside) (200 mM). Plasmids pBT-LGF2 (lcI-
LGF2 fusion) and pTRG-Gal11p (RNAPa subunit–Gal11p fusion)
provided the positive controls, whereas empty pBTnn and
pTRGnn plasmids served as negative controls for in vivo
interaction studies. Positive interactions were judged by the blue
color of the colonies obtained and verified by repeated sub-
clonings and co-transformations. The interactions were further
confirmed by performing liquid b-galactosidase assay as described
earlier [47]. The significance of each interaction was determined
by statistical analysis using Student’s t-test.
Construction of pMTSA vector
The original streptomycin-resistant pCDFDuet vector (Clone-
tech, USA) was modified to have an AraC ORF (open reading
frame) and an MCS carrying SnaB1 restriction site under the
strong pBAD promoter. A DNA fragment of size 2306 bp was
extracted from the original pBADHisAnn vector [31] by digesting
with restriction enzymes XmnI and NdeI. This fragment was cloned
in NdeI/PvuII-digested pCDFDuet vector (2299 bp fragment). E.
coli DH5a competent cells were transformed with the ligation
product and plated on LB-streptomycin plate. Positive clones were
confirmed by restriction digestion and reconfirmed by sequencing
using pBAD forward primer. The resulting expression vector was
designated as pMTSA which now had a CDF origin of replication
(for compatibility and high copy number), an arabinose inducible
pBAD promoter, and an MCS (multiple cloning site) containing a
unique SnaBI restriction site to facilitate blunt end clonings.
Cloning and expression of hcl1, esat6 and cfp10 in
pMTSA vector
ORFs corresponding to these genes were PCR-amplified using
their respective forward and reverse primers (Table 1) followed by
SnaB1 digestion of the PCR products. Subsequent inserts were
cloned in SnaB1-digested pMTSA vector to give HCL1pMTSA,
ESAT6pMTSA and CFP10pMTSA clones respectively. Expres-
sion of proteins in pMTSA clones was checked by transforming
E. coli BL21(DE3) cells and inducing the bacterial culture with
0.2% arabinose in the presence of streptomycin (50 mg/mL).
Whole cell lysates were run on SDS-PAGE and stained with
Coomassie Brilliant Blue R-250 stain. All proteins were expressed
as fusion proteins with 6x His tag at their C-terminal end.
Bacterial three-hybrid studies
Reporter competent cells were transformed with the pTRGnn
and pBTnn vectors carrying the genes corresponding to the
interacting proteins and allowed to grow on X-Gal plates.
Competent cells were prepared from the blue strain and
transformed with pMTSA plasmid encoding the third interacting
protein and grown on X-Gal arabinose indicator plate containing:
kanamycin (50 mg/mL), chloramphenicol (30 mg/mL), tetracy-
cline (12.5 mg/mL), streptomycin (50 mg/mL), X-Gal (80 mg/mL),
IPTG (25 mM), L-arabinose (1%), and X-Gal inhibitor (200 mM).
The blue strain carrying empty pMTSA vector was taken as the
negative control. Colonies were grown at 30uC and observed for
development of blue color. Effect of pMTSA-expressed protein on
the interacting proteins was judged by the change in intensity of
blue color of the colony as compared to the negative control.
Time Course Liquid b-galactosidase Assay
The selected triple co-transformant and the corresponding
negative control were grown to mid-log phase in presence of
40 mM IPTG. Subsequent induction with 1% arabinose wascarried
out. The induced cultures were allowed to grow at 37uC with
shaking. 500 mL of each culture sample was collected at regular
intervals from the time of induction till a further 3 hours. Culture
pellet of the samples of each time point was taken and colorimetric
liquid b-galactosidase assay using ONPG (2-Nitrophenyl b-D-
galactopyranoside) as substrate was carried out as described earlier
[47]. Statistical analysis was carried out by using Student’s t-test.
Arabinose Gradient Liquid b-galactosidase Assay
The selected triple co-transformant and the corresponding
negative control were grown to mid-log phase in the presence of
40 mM IPTG. Induction was done with varying arabinose
concentrations ranging from 0 to 1%. Growth of induced culture
was allowed for a further 3 hours. 500 mL culture pellet of each
sample was taken and assayed colorimetrically by liquid b-
galactosidase assay as described elsewhere [47]. Student’s t-test
was used for the statistical analysis.
Screening of tri-protein complexes
R1 reporter strain was co-transformed with the plasmids
CFP10pMTSA and ESAT6pBTnn, and plated on LB plate
Table 1. The sequence of gene specific forward and reverse
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(30 mg/ml). A single colony was isolated and taken to prepare
chemical competent cells (mCER1). The mCER1 competent cells
were transformed with an M. tuberculosis genomic DNA library
contained in the two-hybrid plasmid pTRGnn. The transformed
cells were plated on X-Gal Streptomycin plate containing 1%
Arabinose and allowed to grow at 30uC for about 40 hrs. The blue
colonies observed on the plates were isolated and grown overnight
in a liquid culture. 10 ml of each culture was taken and patched on
the Arabinose positive and Arabinose negative X-Gal Streptomy-
cin plates. A negative control carrying empty pTRG plasmid in
the mCER1 competent cells was also patched on the same plates.
The plates were incubated and observed for the development of
blue color. The colonies that had turned blue on the Arabinose
negative X-gal Streptomycin plate were taken for further analysis.
Plasmid isolation was carried out by mini-prep and checked by
PCR for the presence of all three plasmids (ESAT6pBTnn,
CFP10pMTSA and the pTRGnn plasmid carrying the library
member). Segregation of the pTRGnn plasmid of each isolate was
then carried out by transforming R1 competent cells with the
plasmid mix and plating them on LB Agar plates containing only
tetracycline (12.5 mg/ml), the resistance marker present on the
pTRG plasmid. Five colonies were picked from each tetracycline
plate and checked by PCR to confirm the absence of
ESAT6pBTnn and CFP10pMTSA plasmids. The PCR-confirmed
colonies from each isolate were picked and taken for plasmid
isolation. The pTRGnn plasmid of each isolate was taken to
retransform the mCER1 competent cells and allowed to grow on
Arabinose positive and Arabinose negative X-Gal plates till the
appearance of blue color. The pTRGnn plasmids were further
sent for sequence analysis.
Construction of M. tuberculosis genomic DNA library
M. tuberculosis H37Rv Genomic DNA was subjected to partial
digestion with restriction enzyme HaeIII. The digested genome
was run on a 1% agarose gel and of the resulting numerous
fragments, those ranging between 500 bp and 3 kb were eluted.
After these fragments were purified, ‘hairpins’ (HP) were ligated to
either side of these fragments [26]. Subsequently, these hairpin
ligated fragments were digested with XbaI and then amplified by
PCR using phosphorylated HP primers, in order to facilitate blunt
ended ligations into SnaBI cut vector pTRGnn.
Cloning, Expression and Purification of proteins
To obtain GST-tagged CFP10 protein, BL21(DE3) cells were
transformed with cfp10 gene cloned in pGex4T3nn [31] and
grown in liquid culture till mid-log phase. The culture was induced
with 1 mM IPTG and grown for 3 hours at 37uC with shaking.
Cells were harvested and lysed. Lysate was treated with 1% Triton
X-100 and centrifuged. The supernatant was incubated with
washed and equilibrated glutathione-agarose beads (Amersham)
with constant shaking at 4uC for 5 hours. Elution of the CFP10-
GST protein from the beads was carried out using elution buffer
(10 mM reduced Glutathione in 10 mM Tris-Cl, pH 8.0). Eluates
were collected and the integrity of protein was checked on SDS-
PAGE. Quantification of protein was done by Bradford assay.
Rv3871 gene was PCR-amplified from the M. tuberculosis
genomic DNA using gene specific primers (Table 1) and cloned
in the pBADHisAnn [31] vector. To obtain His-tagged Rv3871
protein, BL21(DE3) cells harboring Rv3871pBADHisAnn plasmid
were grown till mid-log phase and induced with 0.02% arabinose.
Induced cells were grown for 3 hours with shaking at 37uC and
harvested followed by their lysis. Supernatant was incubated with
washed and equilibrated Ni-NTA agarose beads with shaking for
5 hours at RT. Elution was carried out with Tris-NaCl buffer
containing 250 mM Imidazole. Eluates were collected and
checked on SDS-PAGE. Purified protein was refolded sequentially
by slowly dialyzing against Tris-NaCl buffer (20 mM Tris,
150 mM NaCl) with decreasing concentration of urea. Final
dialysis in 0 M Urea was carried out in presence of 50 mM L-
Arginine. Protein was concentrated using Amicon Ultra Millipore
column.
Purification of HCL1-GST and ESAT6-His proteins was
achieved by the same protocol as described earlier [31].
Far-Western Dot Blot Assay
1 mg of His-tagged purified protein was immobilized as a small
blot on nitrocellulose membrane and allowed to dry. Membrane
was blocked with 5% skimmed milk [in PBS (Phosphate buffer
saline) containing 0.1% Tween] for two hours and washed with
0.1% PBST. The membrane immobilized protein was incubated
overnight with 1 mg/mL solution of GST-tagged binder protein (in
2.5% skimmed milk in 0.1% PBST solution) at 4uC with shaking.
Membrane was again washed with 0.1% PBST and incubated
with anti-GST antibodies (Sigma) (1:2000) for 2 hours. Finally,
incubation with anti-mouse IgG HRPO-labeled secondary
antibodies (Calbiochem) (1:5000) was carried out for 2 hours.
The blot was developed using TMB (3,39,5,59-tetramethylbenzi-
dine) substrate (Sigma).
Quantitative Real Time PCR studies
The selected triple co-transformant and the corresponding
negative control were grown to mid-log phase. Each culture was
subsequently induced with 1% arabinose and allowed to grow for
3 hours. 500 mL of culture was pelleted down and total RNA was
isolated as described previously [31]. DNaseI (Fermentas, USA)
treatment was given as per manufacturer’s instructions. Subse-
quent purification was carried out with RNeasy mini prep kit
(Qiagen) column according to the manufacturer’s protocol. RNA
was checked for integrity and purity by running on 1% denaturing
agarose gel. Quantity and quality check of the RNA was done
using NanoDrop ND-1000 spectrophotometer (Thermo Scientif-
ic). 1 mg of this RNA was reverse-transcribed to cDNA using
BioRad iScript cDNA Synthesis Kit as described by the
manufacturer. Real-time PCR was performed with 1 mL of diluted
cDNA template (equivalent to 8 ng). LacZ forward (59-ATG ACC
ATG ATT ACG GAT TC-39) and reverse primers (59-ATT CGC
CAT TCA GGC TGC GCA-39) and IQ SYBR Green Supermix
(BioRad) were used to prepare the PCR mix. Amplification was
performed in a MiniOpticon (BioRad) Thermocycler using the
protocol described earlier [31]. The gene coding for kanamycin
resistance was used for the normalization of comparative Ct
values. ‘No template’ controls (no cDNA in PCR) were run for
each gene to check for non-specific amplification or primer
dimerization. Statistical significance of each reading was calculat-
ed using Student’s t-test.
Supporting Information
Figure S1 Expression of Rv3871 gene in pMTSA vector
in reporter strain R1. The ability of pMTSA vector to express
the cloned insert in the bacterial two-hybrid Reporter strain R1
was checked by cloning Rv3871 gene in the pMTSA vector and
allowing for expression under arabinose induction. Lane 1: Protein
Ladder (BioRad) Molecular weight in kDa; Lane 2: Uninduced
cell lysate; Lane 3: 0.2% arabinose induced cell lysate expressing
the 65 kDa Rv3871 protein.
(TIF)
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interaction of CFP10 with ESAT6 and Rv3871. (A) 15%
SDS-PAGE stained with coomassie blue showing purified
proteins. Lane M: Protein Ladder (BioRad) Molecular weight in
kDa; Lane 1: Rv3871-His protein (65 kDa); Lane 2: CFP10-GST
protein (36 kDa); Lane 3: HCL1-GST protein (28 kDa); Lane 4:
GST protein (26 kDa); Lane 5: ESAT6-His protein (10 kDa). (B)
Far Western Dot Blot Assay: 1 mg each of purified CFP10-GST
protein and purified GST protein (negative control) were blotted
on two separate strips of nitrocellulose membranes and incubated
with 1 mg/mL solution of purified ESAT6-His or Rv3871-His.
Blots were developed using anti-His antibody. (C) Spot Densito-
metric Analysis for the quantitative estimation of the blots
obtained by Far Western Dot Blot confirmed a strong interaction
between CFP10 and ESAT6, and weaker interaction between
CFP10 and Rv3871.
(TIF)
Figure S3 Representation of protein-protein interaction
of the CFP10 and ESAT6 fusion constructs with Rv3871
in bacterial two-hybrid system. (A) Bacterial two-hybrid
X-Gal plate showing co-transformants CFP10pBTnn +
Rv3871pTRGnn; CFP10-ESAT6pBTnn + Rv3871pTRGnn;
ESAT6-CFP10pBTnn + Rv3871pTRGnn; and pBTnn +
Rv3871pTRGnn (negative control). Two different colonies of
each co-transformant were patched (B) Quantitative analysis by
liquid b-galactosidase assay. The graph is the average of three
separate assays and standard deviation is represented as error bars.
(*, P,0.02; **, P,0.05; ***, P,0.01).
(TIF)
Figure S4 RT-PCR analysis to confirm equivalent
expression of CFP10 and Rv3871 in the ESAT6 positive
and negative three-hybrid strains. No difference in the
transcription level of CFP10 and Rv3871 was observed in the
three-hybrid strains CFP10pBTnn+Rv3871pTRGnn+ESAT6p
MTSA and CFP10pBTnn +Rv3871pTRGnn+pMTSA indicating
that the gradation in the colony blue color of the two strains was
solely due to the differential interaction of CFP10 and Rv3871 in
the strains influenced by the presence or absence of ESAT6.
Kanamycin was used as the internal control. The graph shows an
average of three separate assays.
(TIF)
Figure S5 ESAT6 : HCL1 protein-protein interaction. (A)
Bacterialtwo-hybridX-Galplate patchedwith twoseparate colonies
each, of co-transformants LGF2pBTnn + Gal11pTRGnn (posi-
tive control); ESAT6pBTnn + CFP10pTRGnn; ESAT6pBTnn +
HCL1pTRGnn; and pBTnn + HCL1pTRGnn (negative control)
(B) Quantitative representation by liquid b-galactosidase assay. The
graph is the average of three independent assays and standard
deviation is represented as error bars. (*, P,0.005; **, P,0.02) (C)
Far Western Dot Blot Assay: 1 mg each of purified proteins ESAT6-
His, CFP10-His (negative control), and GST (positive control) were
spotted on nitrocellulose membrane and incubated with 1 mg/mL
solution of purified HCL1-GST protein. Blot was developed using
anti-GST antibodies.
(TIF)
Figure S6 Representation of disruption of ESAT6 :
HCL1 protein-protein interaction by CFP10 in bacterial
three-hybrid system. (A) X-Gal indicator plate with and
without arabinose patched with ESAT6pBTnn + HCL1pTRGnn
+ HLL7pMTSA; and ESAT6pBTnn + HCL1pTRGnn +
CFP10pMTSA. Blue colony turns white when CFP10 is allowed
to express in the presence of 1% arabinose while no effect on
colony color on expression of the dummy non-interacting peptide
HLL7 is seen (B) Time course liquid b-galactosidase assay: b-
galactosidase activity of the triple co-transformants: (m)
ESAT6pBTnn + HCL1pTRGnn + HLL7pMTSA; and (&)
ESAT6pBTnn + HCL1pTRGnn + CFP10pMTSA is plotted
against time-points of bacterial culture growth with 0 time-point
being the point of arabinose induction. Standard deviation of the
activities obtained in three separate assays is shown by error bars.
(P,0.01 at all time-points beyond 90 minutes).
(TIF)
Figure S7 Discovery of a peptide that facilitates the
formation of a tri-protein complex. (A) Patching of colonies
B1-4 on Arabinose positive and negative plates. B4 remains blue
on both plates. (B) Re-cotransformation of mCER1 competent
cells with pTRGnn-based library members B1 and B4. RecoB4
remains blue on both Arabinose negative as well as on Arabinose
positive plates. (C) Peptide sequences of B1 and B4.
(TIF)
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